Chimeric Therapeutics (ASX:CHM) - Webinar Presentation Company Presentations by Finance News Network October 27, 2023 02:38 PM Email Alerts for: ASX:CHM Jennifer Chow - CEO - Chimeric Therapeutics (ASX:CHM) is a clinical-stage therapy company focused on bringing the promise of cell therapy to life for more patients with cancer.
